Phase 3 AIDS-Related Complex trials in Puerto Rico

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

• A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children NCT00000637·Phase 3·Completed·National Institute of Allergy and Infectious Diseases (NIAID)
• A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection NCT00000750·Phase 3·Completed·National Institute of Allergy and Infectious Diseases (NIAID)
• A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT) NCT00000751·Phase 3·Completed·Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
• A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women NCT00000758·Phase 3·Completed·National Institute of Allergy and Infectious Diseases (NIAID)
• The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants NCT00000960·Phase 3·Completed·National Institute of Allergy and Infectious Diseases (NIAID)
• Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors NCT00001073·Phase 3·Completed·National Institute of Allergy and Infectious Diseases (NIAID)
• A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3 NCT00002123·Phase 3·Completed·Pharmacia and Upjohn
• A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3 NCT00002124·Phase 3·Completed·Pharmacia and Upjohn
• A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past NCT00002320·Phase 3·Completed·Glaxo Wellcome
• A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment NCT00002334·Phase 3·Completed·Hoffmann-La Roche
• The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT NCT00002436·Phase 3·Completed·Glaxo Wellcome